| GFACX | LGLFX | GFACX / LGLFX | |
| Total Expense Ratio | 1.35 | 0.64 | 211% |
| Annual Report Gross Expense Ratio | 1.35 | 0.74 | 182% |
| Fund Existence | 25 years | 15 years | - |
| Gain YTD | 5.156 | 2.845 | 181% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 357B | 7.43B | 4,804% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -0.98 | 4.33 | -23% |
| Returns for 3 years | 27.74 | 79.32 | 35% |
| Returns for 5 years | 3.92 | 16.31 | 24% |
| Returns for 10 years | 76.09 | 152.42 | 50% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCGCX | 23.24 | 0.11 | +0.48% |
| BlackRock Advantage Global Investor C | |||
| PGRNX | 23.82 | 0.09 | +0.38% |
| Impax Global Environmental Markets Inv | |||
| SDVRX | 33.70 | -0.08 | -0.24% |
| PGIM Quant Solutions Mid-Cap Val R | |||
| RYAKX | 79.47 | -0.62 | -0.77% |
| Rydex Russell 2000 1.5x Strategy A | |||
| BHSRX | 58.34 | -0.65 | -1.10% |
| BlackRock Health Sciences Opps R | |||